Merck & Company, Inc. · NYSE:MRK
Davis Robert M exercised options for 13,300 Merck & Company, Inc. shares (Form 4)
Traded Apr 29, 2026 · Filed May 1, 2026
On Apr 29, 2026, Davis Robert M (Director, Chairman, CEO & President) exercised options for 13,300 Merck & Company, Inc. shares at US$110.03 for US$1.46M, leaving 450,351 shares. Filed May 1, 2026 (Form 4).
- Options exercised
- 13,300 shares
- Price
- US$110.03
- Value
- US$1.46M
- Holding after
- 450,351 shares
- Trading plan
- No
- Role
- Director, Chairman, CEO & President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Common Stock | Option exercise | 13,300 | US$110.03 | 456,902 | Direct |
| Apr 29, 2026 | Common Stock | Shares withheld for tax | 6,551 | US$110.03 | 450,351 | Direct |